The Venture Codex

Participated · Series B · Nov 2025

Founded in 2014, Fast Beauty runs the hair-colour–specialist chain “fufu,” which counts 146 domestic stores in Japan and 2 outlets in Thailand. By focusing solely on colouring, the company has engineered highly efficient, repeatable salon operations linked to its self-developed Customer Information Platform (cip) that unifies reservations, CRM and KPI tracking. Stylists record diagnostic data during each visit, feeding a membership e-commerce site called “fufu+,” where customers receive personalised product suggestions and content. This closed-loop OMO (Online Merges with Offline) model targets Japanese beauty consumers who demand quality, time efficiency and personalisation. Fast Beauty plans to strengthen its data infrastructure, introduce AI-driven recommendations and pursue product co-development, while improving stylist training and work conditions. Over the next three years it aims to expand to 200 stores globally and accelerate overseas roll-out. No revenue or user figures were disclosed in the article.

Participated · Series A · Aug 2024

Baibys has developed an autonomous sperm selection system for in‑vitro fertilization that analyzes living sperm cells in real time using machine vision and artificial intelligence. The platform evaluates cells by high‑magnification morphological criteria and recognizes structures in motion to assess quality. It then autonomously selects and collects sperm with the highest fertilization potential for microinjection into the egg during IVF procedures. The company says the system relies on state‑of‑the‑art AI algorithms to apply previously established selection criteria. Baibys plans to use newly raised capital to expand operations, advance development efforts, and broaden its business reach. The team includes chairman Itay Itzhaky, CEO Dr. Yaron Silberman, co‑founder & co‑CEO Gal Golov, co‑founder & CMO Dr. Nino Guy Cassuto, and senior R&D and regulatory leaders.

Led · Series B · Mar 2024

InnoJin is a Juntendo University–origin startup using digital technology to research, develop, approve, and commercialize medical-device solutions aimed at medical DX. Its main product, AllerSearch, is a smartphone app that quantifies pollen allergy levels via eye‑image redness analysis and questionnaires and suggests allergy types and countermeasures. AllerSearch also offers a real‑time “everyone’s pollen map” so users can view regional pollen‑allergy conditions to support self‑medication and reduce healthcare costs. The company also offers DryEyeRhythm, a smartphone app for quick dry‑eye checks that lets users evaluate symptoms and supports early detection, prevention, and treatment. A study published in August 2023 showed equivalence between the app’s electronic dry‑eye questionnaire and the conventional paper version, supporting use in remote and online care. InnoJin plans to use new funding to accelerate clinical research and trials for market introduction and to strengthen its organizational base.